Determine the best approach
Biosimilars pose very different challenges than those presented by small molecule generics: higher costs and more demanding requirements in clinical development; a fledgling or nonexistent regulatory framework in markets outside of Europe that can deter global investment; and a need for significant investments in sales and marketing.
Experience, strategies and full-spectrum expertise
Our integrated solutions are designed to meet the distinct demands of bringing biosimilars to market and maximizing their ROI. We partner with all types of customers engaged in producing biologics, bio-betters and biosimilars. Quintiles offers a full range of expertise – scientific, technical, regulatory, clinical, registration and commercialization – critical to development.
We help increase your potential for success by incorporating commercial and regulatory considerations early in the development process. We share your goals to accelerate launch without sacrificing quality, demonstrate safety and efficacy from initial phases to post-market, and build stakeholder trust.
Our dedicated biosimilar intelligence team is ready to provide key regulatory, commercial and clinical insights to help your product realize its full potential.